Analystreport

OASMIA PHARMACE/ADR (NASDAQ: OASM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

OASMIA PHARMACEUTICALS AB AMERICAN DEPOSITARY SHARE  (OASM) 
US:NASDAQ Investor Relations: oasmia.com/en